Amgen’s Stock Soars as $200M India Investment Signals New Growth Era
Amgen’s stock has surged as the biotech giant invests $200 million in a new technology center in India, signaling a renewed focus on growth and innovation.
2 minutes to read
Amgen Captivates Investors with Strong Market Performance and Innovation at Healthcare Conference
Amgen’s recent announcement and strong quarterly earnings have sparked investor enthusiasm, solidifying its position as a market leader and fueling optimism about its future prospects.
2 minutes to read
Amgen’s Stock Fluctuates Amid FDA Hold on Obesity Drug Despite Strong Earnings
Amgen’s stock price sees mixed trends due to a clinical hold on its obesity treatment candidate, but the company remains optimistic about its future prospects and forecasts revenue growth in 2025.
2 minutes to read